🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the trial is to study whether daily treatment with liraglu...
Status
Completed
Location
University of Oulu and Oulu University Hospital, Dept of Children and Adolescents
Start Date
2016-03
Trial ID
NCT02898506
The aim of this study is to explore the effectiveness of liraglutide combin...
Status
Completed
Location
The Third Affiliated Hospital of Sun Yat-sen University
Start Date
2014-08
Trial ID
NCT02147925
This is a multicenter randomized, double-blind, placebo- and active-control...
Status
Terminated
Location
Multiple Locations
Start Date
2015-07-27
Trial ID
NCT02492763
Treatments Being Tested
The main purpose of the trial is to compare the pharmacokinetics of insulin...
Status
Unknown
Location
the First Hospital of Jilin University
Start Date
2024-05-06
Trial ID
NCT06449703
Treatments Being Tested
Incretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Status
Terminated
Location
Gastroenterology Department Erasme Hospital
Start Date
2014-10
Trial ID
NCT02244164
Treatments Being Tested
There are recent advances in therapies for the treatment of Type 2 Diabetes...
Status
Completed
Location
University Hospitals of Leicester NHS Trust, Diabetes Research Centre
Start Date
2013-12-16
Trial ID
NCT02043054
Treatments Being Tested
This trial is conducted in Asia. The aim of this trial is to evaluate safet...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2014-12-15
Trial ID
NCT02321878
Treatments Being Tested
Dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagonlike peptide-1 (GLP-1...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01
Trial ID
NCT01518101
Treatments Being Tested
The main objective of this study is to assess the safety and tolerability o...
Status
Completed
Location
William D Summers MD LLC
Start Date
2018-11-26
Trial ID
NCT03757130
Treatments Being Tested
The study aims to investigate the effects of 3.0 mg of liraglutide on rewar...
Status
Completed
Location
University Hospitals of Geneva
Start Date
2018-03-05
Trial ID
NCT03347890
Treatments Being Tested